Is radiotherapy necessary for intermediate risk ductal carcinoma in situ after breast conserving surgery?
- PMID: 25133091
- PMCID: PMC4132440
- DOI: 10.1186/2193-1801-3-405
Is radiotherapy necessary for intermediate risk ductal carcinoma in situ after breast conserving surgery?
Abstract
Identifying ductal carcinoma in situ (DCIS) patients at highest risk for recurrence after breast conserving surgery (BCS) remains a clinical concern. Subjecting all such patients to radiotherapy may be unnecessary. The Van Nuys Prognostic Index (VNPI) is a simple scoring system for predicting the risk of local recurrence in patients with DCIS. We reviewed patients with DCIS applying the VNPI score system. A total of 184 DCIS patients who underwent surgery at our institution between January 2003 and December 2011 were identified. Patients were not treated according to VNPI guidelines; rather, radiation therapy was applied at each surgeon's discretion. All patients with hormonal receptor positive tumors were treated with hormonal therapy. Pathology reports were reviewed and VNPI scores of each DCIS calculated. Of the 184 patients, 52 (28.3%), 115 (62.5%) and 17 (9.2%) had low, intermediate and high VNPI scores, respectively. Six of the 184 patients (3.3%) developed ipsilateral local recurrence, five in the intermediate and one in the high VNPI score group. Of the five in the intermediate group, three (60%) were in patients with ER-negative tumors. VNPI score itself was not associated with recurrence (P = 0.145). Factors associated with recurrence included tumor size (hazard ratio [HR] 6.88), grade (HR 9.07) and hormone receptor status (HR 11.75). Radiotherapy did not significantly improve recurrence rates in patients with low and intermediate risk DCIS, especially in those with ER-positive tumors. Radiotherapy can be omitted in patients with ER-positive intermediate score DCIS and in patients with low score DCIS.
Keywords: Breast cancer; Ductal carcinoma in situ; ER; Radiotherapy; Recurrence; Van Nuys Prognostic index.
Figures
Similar articles
-
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9. Breast Cancer Res Treat. 2008. PMID: 17687650 Review.
-
Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery.Clin Breast Cancer. 2018 Dec;18(6):441-450.e2. doi: 10.1016/j.clbc.2018.04.002. Epub 2018 Apr 10. Clin Breast Cancer. 2018. PMID: 29709458
-
Fine tuning of the Van Nuys prognostic index (VNPI) 2003 by integrating the genomic grade index (GGI): new tools for ductal carcinoma in situ (DCIS).Breast J. 2011 Jul-Aug;17(4):343-51. doi: 10.1111/j.1524-4741.2011.01091.x. Epub 2011 Jun 6. Breast J. 2011. PMID: 21645166
-
Therapeutic strategy for ductal carcinoma in situ patients according to Van Nuys Prognostic Index.Ann Ital Chir. 2014 May-Jun;85(3):254-9. Ann Ital Chir. 2014. PMID: 25074533
-
Current view on ductal carcinoma in situ and importance of the margin thresholds: A review.Facts Views Vis Obgyn. 2014;6(4):210-8. Facts Views Vis Obgyn. 2014. PMID: 25593696 Free PMC article. Review.
Cited by
-
Ductal carcinoma in-situ arising within benign phyllodes tumours.Ann R Coll Surg Engl. 2018 Apr;100(4):e97-e102. doi: 10.1308/rcsann.2018.0024. Epub 2018 Feb 27. Ann R Coll Surg Engl. 2018. PMID: 29484937 Free PMC article. Review.
-
Effect of radiotherapy on survival of women with locally excised ductal carcinoma in situ of the breast: a Surveillance, Epidemiology, and End Results population-based analysis.Onco Targets Ther. 2015 Jun 10;8:1407-18. doi: 10.2147/OTT.S82087. eCollection 2015. Onco Targets Ther. 2015. PMID: 26089689 Free PMC article.
-
A Comparison of Predicted Ipsilateral Tumor Recurrence Risks in Patients With Ductal Carcinoma in Situ of the Breast After Breast-Conserving Surgery by Breast Radiation Oncologists, the Van Nuys Prognostic Index, the Memorial Sloan Kettering Cancer Center DCIS Nomogram, and the 12-Gene DCIS Score Assay.Adv Radiat Oncol. 2020 Nov 1;6(2):100607. doi: 10.1016/j.adro.2020.10.020. eCollection 2021 Mar-Apr. Adv Radiat Oncol. 2020. PMID: 33912731 Free PMC article.
-
Multidisciplinary Shared Decision Making in the Management of Ductal Carcinoma In Situ of the Breast.Ann Surg Oncol. 2015 Dec;22 Suppl 3(0 3):S516-21. doi: 10.1245/s10434-015-4607-z. Epub 2015 May 19. Ann Surg Oncol. 2015. PMID: 25986869 Free PMC article.
-
Tools to Guide Radiation Oncologists in the Management of DCIS.Healthcare (Basel). 2024 Apr 6;12(7):795. doi: 10.3390/healthcare12070795. Healthcare (Basel). 2024. PMID: 38610216 Free PMC article. Review.
References
-
- Allegra CJ, Aberle DR, Ganschow P, Hahn SM, Lee CN, Millon-Underwood S, Pike MC, Reed SD, Saftlas AF, Scarvalone SA, Schwartz AM, Slomski C, Yothers G, Zon R. National Institutes of Health State-of-the-Science Conference statement: diagnosis and management of ductal carcinoma in situ September 22–24, 2009. J Natl Cancer Inst. 2010;102(3):161–169. doi: 10.1093/jnci/djp485. - DOI - PubMed
-
- Altintas S, Toussaint J, Durbecq V, Lambein K, Huizing MT, Larsimont D, Van Marck E, Vermorken JB, Tjalma WA, Sotiriou C. Fine tuning of the Van Nuys prognostic index (VNPI) 2003 by integrating the genomic grade index (GGI): new tools for ductal carcinoma in situ (DCIS) Breast J. 2011;17(4):343–351. doi: 10.1111/j.1524-4741.2011.01091.x. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources